A CRISPR edit for heart disease.

Subjects :: Amino Acid Substitution
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins deficiency
Angiopoietin-like Proteins genetics
Animals
Antibodies, Monoclonal pharmacology
Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Humanized
Apolipoprotein B-100 deficiency
Apolipoprotein B-100 genetics
Apolipoproteins C genetics
Cholesterol, LDL blood
Disease Models, Animal
Dystrophin genetics
Dystrophin metabolism
Heart Diseases blood
Heart Diseases therapy
Humans
Hypercholesterolemia blood
Hypercholesterolemia genetics
Hypercholesterolemia prevention & control
Lipoprotein(a) deficiency
Lipoprotein(a) genetics
Mice
Muscular Dystrophy, Duchenne genetics
Muscular Dystrophy, Duchenne therapy
Mutation
Myocardial Ischemia drug therapy
Myocardial Ischemia genetics
Myocardial Ischemia prevention & control
PCSK9 Inhibitors
Patient Safety
Proprotein Convertase 9 genetics
Proprotein Convertase 9 metabolism
Stroke drug therapy
Stroke genetics
Stroke prevention & control
CRISPR-Cas Systems genetics
Gene Editing methods
Gene Editing trends
Genetic Therapy methods
Genetic Therapy trends
Heart Diseases genetics
Heart Diseases prevention & control

Full Text Access

Tools